The GRAS Exemption and GRAS Notification: Is There a Need for Significant Changes to Current Policy?

Posted on August 2014 by Mark L. Itzkoff, Of Counsel, Olsson Frank Weeda Terman Matz PC; Joshua Q. Callister, Summer Associate, Olsson Frank Weeda Terman Matz PC

Volume 4 Issue 7 of the FDLI Policy Forum – GRAS Issue 7 of the FDLI Policy Forum focuses on the generally recognized as safe (GRAS) exemption and notification program for food additives . Th...read more

Rethinking the FDA’s Food/Supplement Framework

Posted on April 2014 by Michael Gruver and Glenn Pogust, Kaye Scholer LLP

FDLI Policy Forum Volume 4, Issue 4 was published on April 2, 2014. This issue focuses on the FDA guidance for industry titled, “Distinguishing Liquid Dietary Supplements from Beverages.&rdqu...read more

Ravioli Trees and Tortellini Bushes: What Should Courts Expect from the Reasonable Consumer When it Comes to “Natural” Claims?

Posted on January 2014 by John E. Villafranco, Partner & Katie Bond, Associate Kelley Drye & Warren LLP

This issue of Policy Forum (Volume 4, Number 1, January 29, 2014) –Ravioli Trees and Tortellini Bushes: What Should Courts Expect from the Reasonable Consumer When it Comes to “Natural&...read more

In this Policy Forum, the authors present a set of Core Principles as policy recommendations developed through a series of dialogues convened by the Institute for Environmental Negotiation at the U...read more

Do Pending State Biosimilar Substitution Bills Violate State Constitutional Law Principles of Non-Delegation and Incorporation by Reference?

Posted on September 2013 by Neal Parker Section Head, Legal, Biologics Strategic Development, AbbVie

In this Policy Forum, Parker explains that since Congress enacted the Biologics Price Competition and Innovation Act (BPCIA) in 2010, several state legislatures have introduced and some have enacte...read more

Is Caronia the Most Important FDA Related Judicial Decision of Our Generation?

Posted on August 2013 by Ralph Hall, Professor of Practice at the University of Minnesota Law School, Of Counsel at Faegre Baker Daniels and CEO of MR 3 Medical LLC

This issue of Policy Forum (Volume 3, Issue 14, August 29, 2013)—“Is Caronia the Most Important FDA Related Judicial Decision of Our Generation?” by Ralph Hall (Professor of Pract...read more

“Is FDA Ready to Regulate the World’s First Biotech Food Animal?” (Volume 3, Issue 12, July 24, 2013) “Is Unaccountable Regulatory Delay and Political Interference Undermin...read more

by H. Scott Hurd, DVM, PhD Written by Scott Hurd, Associate Professor, College of Veterinary Medicine at Iowa State University, this Policy Forum discusses the current health problem related to th...read more

Menu Labeling: Did FDA Overreach?

Posted on July 2012 by Erik R. Lieberman

by Erik R. Lieberman, Regulatory Counsel, Food Marketing Institute “Menu Labeling: Did FDA Overreach” is the timely topic addressed in the latest issue of FDLI’s Food and Drug P...read more

by Bert Schwitters and Jonathan W. Emord The authors, Bert Schwitters, Consultant for International Nutrition Company, and Jonathan W. Emord, Esquire, President of Emord & Associates, ...read more